You are here

  • Home
  • Archive
  • Volume 8, Issue 6
  • Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study

Article info

Article menu

Download PDFPDF

XML
Pathology
Research
Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study

Authors

  • Chun-Chi Chang Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan PubMed articlesGoogle scholar articles
  • Wen-Wei Sung School of Medicine, Chung Shan Medical University, Taichung, Taiwan Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Urology, Chung Shan Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Hui-Ting Hsu Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan PubMed articlesGoogle scholar articles
  • Chung-Min Yeh Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan PubMed articlesGoogle scholar articles
  • Chien-Hsun Lee Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan PubMed articlesGoogle scholar articles
  • Ya-Ling Chen Department of Nursing, Changhua Christian Hospital, Changhua, Taiwan PubMed articlesGoogle scholar articles
  • Ta-Chih Liu Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Kun-Tu Yeh School of Medicine, Chung Shan Medical University, Taichung, Taiwan Department of Pathology, Changhua Christian Hospital, Changhua, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Kun-Tu Yeh; 10159{at}cch.org.tw
View Full Text

Citation

Chang C, Sung W, Hsu H, et al
Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study
BMJ Open 2018;8:e021385. doi: 10.1136/bmjopen-2017-021385

Publication history

  • Received December 27, 2017
  • Revised April 12, 2018
  • Accepted May 11, 2018
  • First published June 22, 2018.
Online issue publication 
December 08, 2023
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/